−2.4 TWD
8.46 M TWD
314.50 M TWD
About PHARMOSA BIOPHARM INC
Sector
Industry
CEO
Pei Kan
Website
Headquarters
Taipei
Founded
1990
ISIN
TW0006875008
FIGI
BBG015CHM0J1
Pharmosa Biopharm, Inc. engages in research and development, research, and sale of innovative drugs and medical equipment. Its products include metered dose inhalers, soft mist inhalers, and liquid nebulizers. The company was founded in 1990 and is headquartered in Taipei, Taiwan.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 6875 is 53.2 TWD — it hasn't changed in the past 24 hours. Watch PHARMOSA BIOPHARM INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange PHARMOSA BIOPHARM INC stocks are traded under the ticker 6875.
6875 stock has fallen by −4.32% compared to the previous week, the month change is a −12.21% fall, over the last year PHARMOSA BIOPHARM INC has showed a −40.09% decrease.
6875 reached its all-time high on Jun 29, 2023 with the price of 158.5 TWD, and its all-time low was 30.2 TWD and was reached on Jul 21, 2022. View more price dynamics on 6875 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
6875 stock is 2.07% volatile and has beta coefficient of 0.21. Track PHARMOSA BIOPHARM INC stock price on the chart and check out the list of the most volatile stocks — is PHARMOSA BIOPHARM INC there?
Yes, you can track PHARMOSA BIOPHARM INC financials in yearly and quarterly reports right on TradingView.
6875 net income for the last quarter is −90.06 M TWD, while the quarter before that showed −58.61 M TWD of net income which accounts for −53.65% change. Track more PHARMOSA BIOPHARM INC financial stats to get the full picture.
No, 6875 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 21, 2024, the company has 35.00 employees. See our rating of the largest employees — is PHARMOSA BIOPHARM INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PHARMOSA BIOPHARM INC EBITDA is −296.31 M TWD, and current EBITDA margin is 6.52%. See more stats in PHARMOSA BIOPHARM INC financial statements.
Like other stocks, 6875 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PHARMOSA BIOPHARM INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PHARMOSA BIOPHARM INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PHARMOSA BIOPHARM INC stock shows the strong sell signal. See more of PHARMOSA BIOPHARM INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.